Sarah S Donaldson

10PUBLICATIONS
30CO-AUTHORS
Solid tumoursRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 14, 2023
Common queries in managing rhabdomyosarcoma in low- and middle-income countries: An Indo-North American collaboration.

Sidharth Totadri, Deepak Bansal, Sarah S Donaldson

|Dec 10, 2022
Comment on: Metastatic rhabdomyosarcoma: Evidence of the impact of radiotherapy on survival. A retrospective single-center experience.

Jacquelyn N Crane, Sarah S Donaldson, Sheri L Spunt

|Mar 07, 2022
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group.

Jacquelyn N Crane, Wei Xue, Amira Qumseya

|Feb 07, 2022
An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials.

Josephine H Haduong, Christine M Heske, Wendy Allen-Rhoades

|Jun 14, 2021
Multidisciplinary management of newly diagnosed pediatric large cell neuroendocrine carcinoma of the lung causing hemoptysis.

Cesar P Marquez, Elena G Violari, Quaovi Sodji

|Apr 07, 2021
Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation.

Monika L Metzger, Michael P Link, Amy L Billett

Pageof 2